Monitoring of high-density lipoprotein cholesterol level is predictive of EGFR mutation and efficacy of EGFR-TKI in patients with advanced lung adenocarcinoma.
Onco Targets Ther
; 9: 461-8, 2016.
Article
en En
| MEDLINE
| ID: mdl-26858527
Texto completo:
1
Bases de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Onco Targets Ther
Año:
2016
Tipo del documento:
Article